The A4 study, as it’s known, is focused on people 65 to 85 years old who still have a normal memory, but have early signs of Alzheimer’s.
These people will be administered a drug to see if it will slow or stop the impacts of Alzheimer’s disease.
Dr. Reisa Sperling is the Director at the Center for Alzheimer’s Research and Treatment.
“This is a new study and what’s particularly new about it is trying it in people who don’t yet have symptoms of Alzheimer’s disease. So we’re really trying to change the way we think about Alzheimer’s disease and focus on prevention, rather than most of the trials which unfortunately have not done so well at later stages of Alzheimer’s disease.”
Dr. Sperling says the study has been going on since 2014, and results are expected in 2020.
Sperling says the study will cost around $140 million and is funded by the National Institutes of Health.
Officials say a similar bill was passed last year that granted immunity to prescription drug overdose reports in minors. The new bill would expand immunity to all ages, and all substances.
Al Pscholka is a State Representative and Chairman of the house Appropriations Committee. He developed the bill and its predecessor.
“You know we should never be afraid to save a life so that’s what really started this whole conversation about expanding the Good Samaritan Act, and allowing for people to escape prosecution if it’s a medical emergency and you’re in the commission of saving someone’s life.”
Pscholka says in the state of Michigan, opioid drug overdoses kill more people than car accidents.
He says the original legislation has saved lives, and he hopes the passing of this bill will save more.